Page 2 - Sight Diagnostics News Today

PETAH TIKVA, Israel - Airobotics (TASE: AIRO), a manufacturer of autonomous drones, has signed its first contract with Zzapp Malaria, the creators of an AI platform that develops and supports Malaria eradication strategies. Malaria is a preventable disease spread by the Anopheles mosquito. According to the WHO (World Health Organization), there are over 220 million cases of Malaria

/PRNewswire/ -- Airobotics (TASE: AIRO), a manufacturer of autonomous drones, has signed its first contract with Zzapp Malaria, the creators of an AI platform...

The firm plans to further develop its blood typing technology.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Whether it’s in diagnostics, treatment or care management, Israel's innovators are busy inventing and adapting technologies to ease the coronavirus burden on the world.

ZzappMalaria wins $3m IBM Watson AI XPRIZE Israeli startup’s AI platform tailors and monitors location-specific antimalarial strategies; also won the Peoples Choice Award in the competition. June 27, 2021, 1:45 pm Cap: ZzappMalaria’s team accepting the $3 million grand prize in the IBM Watson AI XPRIZE Competition. Photo courtesy of XPRIZE Jerusalem-based ZzappMalaria, developer of a system to help eliminate malaria-carrying mosquitos, won the$3 million grand prize in the IBM Watson AI XPR...

Share this article Health Canada Approval Enables Quick and Accurate Blood Testing TORONTO, April 27, 2021 /CNW/ - AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed Clozapine. This medication, indicated for patients with Treatment Resistant Schizophrenia, requires regular blood monitoring.  Sight Diagnostics Ⓡ received Health Canada approval for its Sight OLO Ⓡ analy...

infinityApril 17, 2021 Virtual Diagnostic Market Growth Factor, Leading Companies, Industry Challenges, Share, Region, and Global Forecast 2021-2027 The global Virtual Diagnostic Market analysis study focuses on the confined main statistical outlook for the Virtual Diagnostic industry in order to provide their consumers with revenue generation in leading them in facing the market’s obstacles. The analysis includes an exhaustive examination of several factors such as global distribution, busin...

Israeli company Sight Diagnostic’s Sight OLO blood diagnostics device. Photo: Sight Diagnostics via Facebook. CTech – Sight Diagnostics, an Israeli company that delivers lab-grade Full Blood Count (FBC) results in just a few minutes, has deployed its Sight OLO solution at the John Radcliffe Hospital, part of Oxford University Hospitals NHS Foundation. The deployment means that patients who attend the emergency departments have access to quick FBC testing as part of a rapid AI triage system ...

OurCrowd Has Stellar 2020, Expects Solid 2021: A Discussion with OurCrowd CEO Jon Medved January 13, 2021 @ 9:30 am By JD Alois OurCrowd is a leading venture marketplace where smaller (accredited) investors can participate in private securities offerings alongside really big investors. A recent example is where JumpCloud, an enterprise cloud service provider, raised $100 million in a Series E Round. OurCrowd’s name was alongside high profile VCs underlining its ability to gain access to vent...